solifenacin
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Vesicare, Vesicare LS |
| Other names | YM905 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a605019 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 90% |
| Protein binding | 98% |
| Metabolism | CYP3A4 |
| Metabolites | Glucuronide, N-oxide, others |
| Elimination half-life | 45 to 68 hours |
| Excretion | Kidney (69.2%) and fecal (22.5%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C23H26N2O2 |
| Molar mass | 362.473 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
solifenacin (tsz. solifenacins)
- solifenacin - Szótár.net (en-hu)
- solifenacin - Sztaki (en-hu)
- solifenacin - Merriam–Webster
- solifenacin - Cambridge
- solifenacin - WordNet
- solifenacin - Яндекс (en-ru)
- solifenacin - Google (en-hu)
- solifenacin - Wikidata
- solifenacin - Wikipédia (angol)